These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 1986099)

  • 21. The use of interferon alfa-2a for life-threatening hemangiomas.
    MacArthur CJ; Senders CW; Katz J
    Arch Otolaryngol Head Neck Surg; 1995 Jun; 121(6):690-3. PubMed ID: 7772325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon alfa-2a therapy for life-threatening hemangiomas of infancy.
    Ezekowitz RA; Mulliken JB; Folkman J
    N Engl J Med; 1992 May; 326(22):1456-63. PubMed ID: 1489383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon alpha-2a therapy of consumptive coagulopathy in Kasabach-Merritt syndrome.
    Klein C; Hauser M; Hadorn HB
    Eur J Pediatr; 1992 Dec; 151(12):919. PubMed ID: 1473549
    [No Abstract]   [Full Text] [Related]  

  • 24. The response of parotid hemangiomas to the use of systemic interferon alfa-2a or corticosteroids.
    Blei F; Isakoff M; Deb G
    Arch Otolaryngol Head Neck Surg; 1997 Aug; 123(8):841-4. PubMed ID: 9260550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a.
    White CW; Wolf SJ; Korones DN; Sondheimer HM; Tosi MF; Yu A
    J Pediatr; 1991 Jan; 118(1):59-66. PubMed ID: 1986099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of hemangiomatosis with recombinant interferon alfa.
    White CW
    Semin Hematol; 1990 Jul; 27(3 Suppl 4):15-22. PubMed ID: 2197730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The interferon alfa-2a treatment of the severe form of the Kasabach-Merritt syndrome with neonatal onset].
    González de Dios J; Moya Benavent M; Herranz Sánchez Y; Juste Ruiz M; González Montero R
    An Esp Pediatr; 1996 Feb; 44(2):179-83. PubMed ID: 8830584
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of hemangioma in children with recombinant interferon].
    Illum NO
    Ugeskr Laeger; 1992 Nov; 154(48):3408-10. PubMed ID: 1462451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multimodal management of diffuse neonatal hemangiomatosis.
    Stratte EG; Tope WD; Johnson CL; Swanson NA
    J Am Acad Dermatol; 1996 Feb; 34(2 Pt 2):337-42. PubMed ID: 8655722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kasabach-Merritt syndrome: a case review.
    Szlachetka DM
    Neonatal Netw; 1998 Feb; 17(1):7-15. PubMed ID: 9526357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Which hemangiomas to treat--and how?
    Frieden IJ
    Arch Dermatol; 1997 Dec; 133(12):1593-5. PubMed ID: 9420551
    [No Abstract]   [Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.